Principal investigator shares more about pediatric COVID-19 vaccine trials
Dr. Salma Elfaki, principal investigator for Accel Research Sites, was recently interviewed by WFTV in Orlando. She was interviewed to discuss… Read More
Category: Company News
Accel Research Sites appoints new CEO
Lora Parahovnik, PhD, promoted from SVP of Clinical Operations Read More
Accel Research Sites COVID-19 vaccine participant interviewed by WTVM in Birmingham
As more people are receiving the COVID-19 vaccine, so are our trial participants. Many of those who received the placebo during… Read More
Accel Research Sites COVID-19 vaccine participant interviewed by News 6 in Orlando
Now that Moderna and Pfizer’s COVID-19 vaccines are approved, participants in the studies are being unblinded. They are finding out if… Read More
Lead investigator for COVID-19 vaccine trial interviewed on Birmingham TV station
Dr. Hayes T. Williams, a lead investigator for Accel Research Sites’ COVID-19 vaccine trials, was recently interviewed by WBRC in Birmingham… Read More
Lead investigator at Accel Research Sites joins esteemed panel on Orlando news station
Many people have questions about COVID-19 and the vaccination process. Fox 35 in Orlando put together a qualified panel to answer… Read More
Principal investigator for COVID-19 vaccine interviewed by The Ledger
Dr. James Andersen, a principal investigator for Accel Research Sites’ COVID-19 vaccine trials, was recently interviewed. The interview was conducted by… Read More
Principal investigator for COVID-19 vaccine trial interviewed on Tampa TV station
Dr. James Andersen, a principal investigator for Accel Research Sites’ COVID-19 vaccine trials, was recently interviewed. The interview was done by… Read More
